Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. (2017)
Attributed to:
Biomedical Catalyst – Antibody Directed Phototherapy for Oesophageal Adenocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.15340
PubMed Identifier: 28212575
Publication URI: http://europepmc.org/abstract/MED/28212575
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncotarget
Issue: 15
ISSN: 1949-2553